Brief: Theravance Biopharma Q3 Operating Income USD -6.455 Million
10/11/2025 21:05
Nov 10 (Reuters) - Theravance Biopharma Q3 revenue USD 19.99 million vs. IBES estimate USD 19.3 million. Q3 net income USD 3.615 million Q3 adjusted net income USD 2.26 million vs. IBES estimate USD -6.76 million Q3 EPS USD 0.07
Recent news on Theravance Biopharma
See all newsIreland's Theravance Biopharma Q1 revenue beats estimates on YUPELRI growth
Ireland's Theravance Biopharma Q4 revenue misses expectations
Corrected: BRIEF-Theravance Biopharma Q4 Operating Income USD 20.012 Million
U.S. STOCKS ON THE MOVE-Versant Media Group, Lithium miners, Expedia Group
U.S. STOCKS ON THE MOVE-Expedia Group, Blue Owl Capital, Enphase Energy